Theravance Biopharma
TBPH
TBPH
100 hedge funds and large institutions have $1.27B invested in Theravance Biopharma in 2016 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 43 increasing their positions, 23 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
2% more funds holding
Funds holding: 98 → 100 (+2)
72% less call options, than puts
Call options by funds: $272K | Put options by funds: $972K
Holders
100
Holding in Top 10
4
Calls
$272K
Puts
$972K
Top Buyers
| 1 | +$27.3M | |
| 2 | +$24.4M | |
| 3 | +$13.7M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$9.96M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.1M |
Top Sellers
| 1 | -$14.8M | |
| 2 | -$7.37M | |
| 3 | -$5.32M | |
| 4 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$3.98M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$3.62M |